Preferred Label : Schwannomatosis 1;
Symbol : SWN1;
CISMeF acronym : SWNTS1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Neurilemmomatosis, congenital cutaneous; SWNTS1;
Description : Schwannomatosis, also known as neurilemmomatosis, first reported by Niimura (1973)
as neurofibromatosis type 3, is characterized by multiple cutaneous neurilemmomas
and spinal schwannomas, without acoustic tumors or other signs of neurofibromatosis
I (NF1; 162200) or neurofibromatosis II (NF2; 101000). In neurilemmomas, the tumor
consists of Schwann cells. Some patients may develop meningiomas (van den Munckhof
et al., 2012).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the neurofibromin-2 gene (NF2, 607379.0017); Caused by mutation in the SWI/SNF-related, matrix-associated, actin-dependent regulator
of chromatin, subfamily B, member 1 gene (SMARCB1, 601607.0005);
Neoplasia : Multiple schwannomas; Meningiomas;
Prefixed ID : #162091;
Origin ID : 162091;
UMLS CUI : C4048809;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
Validated automatic mappings to NTBT